作者: M BURG , A VASHIST , R SOUFER
DOI: 10.1016/J.NUCLCARD.2005.06.085
关键词:
摘要: A body of research published over the past 20 years has revealed much concerning prevalence, pathophysiology, and prognosis associated with MSI while also providing promising approaches to improving event-free survival rates in those who have this form ischemia. Although many important questions remain, we believe that findings date provide sufficient evidence for planning, development, execution a large-scale clinical trial. Such trial would not only further testing prognostic significance treatment effects but explorations into remaining pathophysiology elaborating possible additional modalities treatment. Our collective expertise nuclear cardiology provides an opportunity establish diagnostic standardization, approach, assessment We are position be thought leaders complex manifestation ischemia substantial impact.